Health ministry seeks revision of some pharmaceutical affairs law

Published: 2006-10-30 06:59:00

Updated: 2006-10-30 06:59:00

The Ministry of Health and Welfare said it will revise the current pharmaceutical affairs law in a bid to promote more efficient drug-related administration after consultation with related organizations until November 14. Salient points of the newly revised pharmaceutical affairs law are summariz...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK